Dietary Supplement Labeling and Advertising Claims: Are Clinical Studies on the Full Product Required?
Food and Drug Law Journal, Vol. 64, No. 1
The article provides an overview of the relevant substantiation requirements for dietary supplement claims and then reviews FTC’s and FDA’s guidance on key ingredient claims; relevant case law; use of key ingredient claims in the advertising of other consumer products; and the National Advertising Division of the Better Business Bureau, Inc.’s (NAD’s) approach to evaluating key ingredient claims for dietary supplements.
Download the Food and Drug Law Journal article below. With permission from FDLI.